ArticleScientific reports2026
Precise peak width estimation for solving key challenges in biosignal and spectral analysis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Accurately estimating peak width and wave duration (WD) is a significant challenge across various scientific disciplines. Traditional methods, such as Full Width at Half Maximum (FWHM), often encounter difficulties with overlapping peaks, asymmetric patterns, noisy data, and, especially, multi-channel data where these challenges multiply. This paper introduces a novel approach for estimating peak width and WDs in curve-fitting applications, leveraging the oscillatory nature of signals through Frequency Modulated Möbius (FMM) decomposition. We derive a parametric expression for FWHM and propose a novel WD measure. Beyond being both mathematically and physiologically sound, this method offers several advantages, including a straightforward parametric formulation, robust estimation, and flexibility to handle single and overlapping peaks, as well as peaks recorded across multiple channels. While potential applications extend across disciplines, we demonstrate this method's effectiveness in addressing critical challenges in electrocardiogram (ECG) signal and spectroscopic analysis. In ECG analysis, the WD measure effectively estimates ECG segments that capture critical aspects of cardiac electrical activity. In spectroscopy, we evaluate the new FWHM estimator, a key parameter for determining spectral resolution and material properties. Extensive testing confirms the suitability and robustness of the new measures, outperforming standard techniques in both applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.